Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-65894

Single-particle
3.27 Å
EMD-65894
3D View Gallery
Deposition: 19/08/2025
Map released: 14/01/2026
Last modified: 14/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-65894
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9wdp summary report (pdf.gz) Map and 9wdp FULL report (pdf.gz)
EMICSS annotations (xml)

Cyro-EM structure of prefusion RSV fusion glycoprotein in complex with Ziresovir and motavizumab Fab

EMD-65894

Single-particle
3.27 Å
EMD-65894
3D View Gallery
Deposition: 19/08/2025
Map released: 14/01/2026
Last modified: 14/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Mus musculus, Human respiratory syncytial virus A2, Tequatrovirus T4
Sample: prefusion RSV fusion glycoprotein in complex with ziresovir and motavizumab Fab
Fitted models: 9wdp

Deposition Authors: Zhang W, Yan MR, Zou JJ, Peng W

Molecular Mechanism of Ziresovir Targeting the Fusion Glycoprotein of Respiratory Syncytial Virus
Zhang W, Yan MR, Zou JJ, Peng W
To Be Published